Japan 2012 approvals rise as regulatory reforms flow through
This article was originally published in SRA
Executive Summary
A total of 44 new molecular and new biologic therapeutic entities (including new vaccines) were approved in Japan in calendar 2012, marking a substantial one-third increase over the33 in the previous year, according to Scrip Intelligence, a sister publication of Scrip Regulatory Affairs.